Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Chesnara ( (GB:CSN) ) is now available.
Chesnara plc has received UK regulatory approval for its proposed acquisition of HSBC Life (UK) Limited for £260 million, with plans to complete the transaction by the end of January 2026. This acquisition aligns with Chesnara’s strategy of expanding through value-adding acquisitions, potentially enhancing its market position and offering new growth opportunities in the life and pensions sector.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Spark’s Take on GB:CSN Stock
According to Spark, TipRanks’ AI Analyst, GB:CSN is a Outperform.
Chesnara’s overall stock score is driven by strong technical indicators and positive corporate events, reflecting confidence in the company’s strategy. Financial performance shows improvement, though challenges in profitability and equity management persist. The high dividend yield provides valuation support despite a negative P/E ratio.
To see Spark’s full report on GB:CSN stock, click here.
More about Chesnara
Chesnara plc is a European life and pensions consolidator listed on the London Stock Exchange. It manages nearly one million policies, operating as Countrywide Assured in the UK, Scildon in the Netherlands, and Movestic in Sweden. The company follows a three-pillar strategy focusing on efficient policy administration, profitable new business, and value-adding acquisitions. Chesnara has consistently increased its dividend for 20 years.
Average Trading Volume: 493,781
Technical Sentiment Signal: Buy
Current Market Cap: £646.2M
See more data about CSN stock on TipRanks’ Stock Analysis page.